{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:57:38Z","timestamp":1761663458489},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.reuma.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T15:12:42Z","timestamp":1462029162000},"page":"156-159","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Are RA patients from a non-endemic HCV population screened for HCV? A cross-sectional analysis of three different settings"],"prefix":"10.1016","volume":"13","author":[{"given":"Cassandra Michelle","family":"Skinner-Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Erhard-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Alberto","family":"Garza-Elizondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Antonio","family":"Esquivel-Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Abud-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Ulises","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vega-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Arana-Guajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2016.03.006_bib0085","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.reuma.2016.03.006_bib0090","doi-asserted-by":"publisher","first-page":"s395","DOI":"10.1590\/S0036-36342007000900011","article-title":"Seroprevalencia de la hepatitis C en adultos de M\u00e9xico: \u00bfun problema de salud p\u00fablica emergente?","volume":"49","author":"Valdespino","year":"2007","journal-title":"Salud p\u00fablica M\u00e9x"},{"key":"10.1016\/j.reuma.2016.03.006_bib0095","unstructured":"AASLD\/IDSA\/IAS-USA. HCV testing and linkage to care. Recommendations for testing, managing, and treating hepatitis C. http:\/\/www.hcvguidelines.org\/full-report\/hcv-testing-and-linkage-care [accessed 24.04.14]."},{"key":"10.1016\/j.reuma.2016.03.006_bib0100","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.reuma.2016.03.006_bib0105","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"15","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2016.03.006_bib0110","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.reuma.2013.10.006","article-title":"Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis","volume":"10","author":"Cardiel","year":"2014","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2016.03.006_bib0115","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2016.03.006_bib0120","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2016.03.006_bib0125","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.reuma.2016.03.006_bib0130","first-page":"s220","article-title":"The health system of Mexico","volume":"53","author":"G\u00f3mez Dant\u00e9s","year":"2011","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.reuma.2016.03.006_bib0135","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s10067-014-2612-4","article-title":"The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis","volume":"33","author":"Conway","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reuma.2016.03.006_bib0140","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/bfgp\/eln027","article-title":"Systems biology at the Institute for Systems Biology","volume":"7","author":"Hood","year":"2008","journal-title":"Brief Finct Genomic Proteomic"},{"key":"10.1016\/j.reuma.2016.03.006_bib0145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.arbres.2010.09.009","article-title":"P4 medicine: the future around the corner","volume":"47","author":"Sobradillo","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.reuma.2016.03.006_bib0150","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2796.2011.02498.x","article-title":"Systems cancer medicine: towards realization of predictive, preventive, personalized, and participatory (P4) medicine","volume":"271","author":"Tian","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.reuma.2016.03.006_bib0155","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/rheumatology\/ker190","article-title":"Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review","volume":"50","author":"Brunasso","year":"2011","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.reuma.2016.03.006_bib0160","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.3748\/wjg.v20.i13.3516","article-title":"Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease","volume":"20","author":"Sansone","year":"2014","journal-title":"World J Gastroenterol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X16000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T17:22:59Z","timestamp":1536772979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X16000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1699258X16000504"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2016.03.006","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are RA patients from a non-endemic HCV population screened for HCV? A cross-sectional analysis of three different settings","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}